Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China · Delayed Price · Currency is CNY 28.20
+2.27 (8.75%)
Nov 3, 2025, 2:45 PM CST
SHE:000766 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 57.48 | 56.44 | 43.93 | 30.15 | 35.27 | -359.5 | Upgrade |
Depreciation & Amortization | 66.77 | 66.77 | 74.74 | 71.62 | 69.39 | 67.71 | Upgrade |
Other Amortization | 0.61 | 0.61 | 0.29 | 0.18 | 0.61 | 1.99 | Upgrade |
Loss (Gain) From Sale of Assets | 0.17 | 0.17 | 0.21 | 0.02 | -0.83 | -57.58 | Upgrade |
Asset Writedown & Restructuring Costs | -0.12 | -0.12 | -0.22 | 0.11 | 0.59 | 0.43 | Upgrade |
Loss (Gain) From Sale of Investments | -2.42 | -2.42 | 2.61 | -1.3 | -11.13 | -0.99 | Upgrade |
Provision & Write-off of Bad Debts | 3.65 | 3.65 | 8.98 | -3.09 | -3.19 | 131.78 | Upgrade |
Other Operating Activities | 45.2 | 86.83 | 82.54 | 91.05 | 89.12 | 132.24 | Upgrade |
Change in Accounts Receivable | 2.64 | 2.64 | -50.56 | - | -5.87 | 275.57 | Upgrade |
Change in Inventory | -10.47 | -10.47 | 10.18 | 4.12 | 54.74 | -31.63 | Upgrade |
Change in Accounts Payable | -42.8 | -42.8 | -60.45 | 3.03 | -116.27 | -61.03 | Upgrade |
Operating Cash Flow | 122.15 | 162.75 | 112.78 | 198.16 | 138.33 | 80.71 | Upgrade |
Operating Cash Flow Growth | -12.22% | 44.31% | -43.09% | 43.25% | 71.40% | 7.81% | Upgrade |
Capital Expenditures | -55.59 | -49.17 | -26.67 | -23.74 | -25.48 | -19.16 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | 0.05 | 0.33 | 1.59 | 1.01 | 30.28 | Upgrade |
Cash Acquisitions | - | - | - | - | 0.03 | - | Upgrade |
Divestitures | - | - | - | - | 16.68 | 1.58 | Upgrade |
Investment in Securities | 0 | 0 | -0.93 | 0.91 | 0.01 | -497.02 | Upgrade |
Other Investing Activities | 24.53 | - | 100.4 | - | 12 | -40.35 | Upgrade |
Investing Cash Flow | -31.05 | -49.12 | 73.13 | -21.24 | 4.25 | -524.66 | Upgrade |
Long-Term Debt Issued | - | 234.5 | 130 | 1,607 | 40 | 1,240 | Upgrade |
Long-Term Debt Repaid | - | -135.87 | -227.45 | -1,663 | -296.9 | -534.75 | Upgrade |
Net Debt Issued (Repaid) | 38.13 | 98.63 | -97.45 | -55.82 | -256.9 | 704.85 | Upgrade |
Common Dividends Paid | -82.19 | -84.98 | -83.32 | -88.6 | -97.5 | -130.85 | Upgrade |
Other Financing Activities | 3.48 | -20.55 | -73.09 | - | - | 6 | Upgrade |
Financing Cash Flow | -40.58 | -6.89 | -253.86 | -144.42 | -354.4 | 580 | Upgrade |
Net Cash Flow | 50.53 | 106.73 | -67.95 | 32.5 | -211.82 | 136.04 | Upgrade |
Free Cash Flow | 66.56 | 113.58 | 86.11 | 174.42 | 112.85 | 61.55 | Upgrade |
Free Cash Flow Growth | -35.25% | 31.89% | -50.63% | 54.56% | 83.35% | 343.45% | Upgrade |
Free Cash Flow Margin | 5.34% | 8.59% | 5.85% | 11.86% | 7.45% | 5.54% | Upgrade |
Free Cash Flow Per Share | 0.07 | 0.12 | 0.10 | 0.17 | 0.13 | 0.06 | Upgrade |
Cash Income Tax Paid | 138.51 | 85.12 | 115.33 | 85.7 | 96.82 | 132.91 | Upgrade |
Levered Free Cash Flow | -43.86 | -21.21 | 28.71 | 96.14 | 112.66 | 83.36 | Upgrade |
Unlevered Free Cash Flow | 8.68 | 31.91 | 80.68 | 151.64 | 173.41 | 161.65 | Upgrade |
Change in Working Capital | -49.18 | -49.18 | -100.31 | 9.43 | -41.51 | 164.62 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.